Takashi Miida

Has grant

Professor

Juntendo University Graduate School of Medicine

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Microbiology Microbiology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Takashi Miida is a Professor at Juntendo University Graduate School of Medicine in Japan. His research focuses on lipoprotein standardization, antimicrobial susceptibility, and the role of calcium in neuronal health related to Alzheimer's disease. Recent publications include studies on the harmonization of immunoassays for lipoproteins and antimicrobial treatments for multidrug-resistant infections. He actively contributes to guidelines for cardiovascular disease prevention and has been involved in the identification of various bacterial species using innovative techniques.

Recent Grants

Grant: Close

Factors affecting serum free glycerol concentration, and international standardization of triglyceride concentration

Open Date: 2015-01-01

Close Date: 2018-01-01

Articles (23)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (1)

MacRae Linton

Professor of Medicine

Vanderbilt University Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Takashi Miida

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (23)

Harmonization of Lipoprotein(a) Immunoassays Using A Serum Panel Value Assigned with The IFCC-Endorsed Mass Spectrometry-Based Reference Measurement Procedure as A First Step Towards Apolipoprotein Standardization

Identification of <i>Elizabethkingia</i> species by MALDI-TOF MS proteotyping

Antimicrobial susceptibility analysis of isepamicin combination treatments in <i>Mycobacterium abscessus</i> species

Isolation and identification of <i>Wickerhamiella tropicalis</i> from blood culture by MALDI-MS

Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022

Low serum carnitine level is associated with increased urinary carnitine excretion in late pregnancy

Multidrug-resistant Klebsiella pneumoniae clinical isolates producing NDM- and OXA-type carbapenemase in Nepal

Multidrug-resistant Klebsiella pneumoniae clinical isolates producing NDM- and OXA-type carbapenemase in Nepal

Transitional Medicine of Intractable Primary Dyslipidemias in Japan

Carvedilol suppresses ryanodine receptor-dependent Ca<SUP>2+</SUP> bursts in human neurons bearing <i>PSEN1</i> variants found in early onset Alzheimer's disease

Global Standardization of Lipid/Lipoprotein Testing

Higher concentration of 25-hydroxycholesterol in treatment-naïve patients with type 2 diabetes compared to healthy individuals

High-density lipoproteins mediate small RNA intercellular communication between dendritic cells and macrophages

High-density lipoproteins mediate small RNA intercellular communication between dendritic cells and macrophages

Blood Sampling on Admission in Patients with Acute Coronary Syndrome

Evaluation of bone marrow aspirates using the automated hematology analyzer Sysmex XN-3000

Lipoprotein lipase concentration in umbilical cord blood reflects neonatal birth weight

Performance evaluation of the Ortho VITROS SARS-CoV-2 Spike-Specific Quantitative IgG test by comparison with the surrogate virus neutralizing antibody test and clinical assessment

The synergetic effect of sitafloxacin-arbekacin combination in the Mycobacterium abscessus species

Detection of SARS-CoV-2 omicron variants by immunochromatographic kit

Detection of SARS-CoV-2 omicron variants by immunochromatographic kit

Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies

Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies

Collaborators (1)

MacRae Linton

Make your next move.